🇺🇸 FDA

Drug profile · INN

maribavir

LIVTENCITY

approved J05AX10
US status
approved
Patents linked
2
News articles
0

Quick answer

maribavir (LIVTENCITY) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN maribavir
Brand LIVTENCITY
Route ORAL
Formulation TABLET
ATC code J05AX10
Originator Takeda Pharmaceuticals International AG

Related patents

Search patents →

  1. US 12213989

    Use of maribavir in treatment regimens

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11684632

    Maribavir isomers, compositions, methods of making and methods of using

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is maribavir?

maribavir (LIVTENCITY) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for maribavir?

LIVTENCITY is a marketed brand name for maribavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of maribavir?

maribavir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.